Drug delivery device with messaging label
View Patent ↗A drug delivery device includes a housing, a reservoir, a cannula, one or more light sources, a label, and a controller. The reservoir is disposed within the housing. The cannula is connected to the reservoir for delivering a drug from the reservoir to the patient. The light sources are disposed adjacent the exterior surface of the housing, and each serves to indicate one of one or more operational conditions of the device. The label is fixed to the housing adjacent the light sources, and includes one or more informational messages. Each informational message is aligned with one of the light sources for conveniently conveying to a user an operational condition of the device as indicated by the corresponding light source. Finally, the controller is operably connected to the reservoir and the light sources. The controller is configured to actuate the reservoir to deliver the drug, and to selectively illuminate the one or more light sources based on the operational condition of the drug delivery device.
1 . A drug delivery device comprising:
a housing having an interior surface and an exterior surface, the interior surface defining an interior space;
a reservoir disposed within the interior space of the housing, the reservoir configured to store a volume of a drug to be delivered to a patient;
a cannula operably connected to the reservoir and adapted to extend at least partially beyond the exterior surface of the housing for delivering the drug to the patient;
one or more visual indicators; and
one or more informational messages disposed on the housing, each informational message for conveying to a user an operational condition of the drug delivery device,
wherein at least one of the one or more informational messages includes a textual and/or symbolic message disposed on the housing describing a delivery-complete condition of the drug delivery device and aligned with at least one visual indicator of the one or more of visual indicators, and
wherein the one or more informational messages comprises first through third informational messages,
the first informational message including at least a first textual and/or symbolic message describing a ready-state condition of the drug delivery device,
the second informational message including at least a second textual and/or symbolic message describing a delivery-in-process condition of the drug delivery device, and
the third informational message including at least a third textual and/or symbolic message describing the delivery-complete condition of the drug delivery device.
2 . The device of claim 1 , wherein each informational message includes a visual indicia regarding a status of the drug delivery device.
3 . The device of claim 1 , wherein the housing is adapted to be attached to a patient with an adhesive disposed on a portion of the exterior surface of the housing.
4 . The device of claim 1 , wherein the cannula includes (a) a rigid hollow needle, (b) a soft hollow catheter, (c) a rigid solid needle and a soft hollow catheter, or (d) a rigid hollow needle and a soft hollow catheter.
5 . The device of claim 1 , further comprising a button disposed on the housing adjacent to the one or more informational messages, the button configured to initiate operation of the drug delivery device.
6 . The device of claim 5 , wherein the button is disposed so that it extends through the exterior surface of the housing.
7 . The device of claim 1 , the one or more visual indicators disposed adjacent the exterior surface of the housing, at least one visual indicator of the one or more visual indicators used in conjunction with the at least one informational message to signal that the drug delivery device is operating according to a specific operating condition.
8 . The device of claim 1 , further comprising a drug product stored in the reservoir, wherein the drug product comprises one of: (a) a monoclonal antibody (IgG) that binds human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), (b) a granulocyte colony- stimulating factor (G-CSF), (c) a product that targets or modulates sclerostin, or (d) a product that relates to calcitonin gen-related peptide (CGRP).
9 . A method of manufacturing a drug delivery device having a housing, a reservoir for storing a volume of a drug, a cannula operably connected to the reservoir for delivering the drug to a patient, one or more visual indicators, and one or more informational messages disposed on the housing for indicating one or more operational states of the drug delivery device, the method comprising:
disposing a button on the housing adjacent to the one or more informational messages, the button configured to initiate operation of the drug delivery device and extend through an interior surface of the housing;
positioning at least portions of the reservoir and the cannula into an interior space of the housing; and
closing the housing;
the one or more informational messages disposed on the housing such that each informational message conveys to a user an operational condition of the drug delivery device,
wherein at least one of the one or more informational messages includes a textual and/or symbolic message disposed on the housing describing a delivery-complete condition of the drug delivery device and aligned with at least one visual indicator of the one or more of visual indicators.
10 . The method of claim 9 , further comprising at least partly filling the reservoir with one of: (a) a monoclonal antibody (IgG) that binds human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), (b) a granulocyte colony-stimulating factor (G-CSF), (c) a product that targets or modulates sclerostin, or (d) a product that relates to calcitonin gen-related peptide (CGRP).
11 . The method of claim 9 , disposing an adhesive on a portion of an exterior surface of the housing, the adhesive adapted to attach the housing to a patient.
12 . The method of claim 9 , further comprising disposing the one or more visual indicators within the interior space of the housing and adjacent to an exterior surface of the housing when the housing is closed, at least one visual indicator of the one or more visual indicators used in conjunction with the one or more informational messages to signal that the drug delivery device is operating according to a specific operating condition.
13 . A method of manufacturing a drug delivery device having a housing, a reservoir for storing a volume of a drug, a cannula operably connected to the reservoir for delivering the drug to a patient, one or more visual indicators, and one or more informational messages disposed on the housing for indicating one or more operational states of the drug delivery device, the method comprising:
positioning at least portions of the reservoir and the cannula into an interior space of the housing;
closing the housing; and
disposing the one or more visual indicators within the interior space of the housing and adjacent to an exterior surface of the housing when the housing is closed, at least one visual indicator of the one or more visual indicators used in conjunction with the one or more informational messages to signal that the drug delivery device is operating according to a specific operating condition;
the one or more informational messages disposed on the housing such that each informational message conveys to a user an operational condition of the drug delivery device,
wherein at least one of the one or more informational messages includes a textual and/or symbolic message disposed on the housing describing a delivery-complete condition of the drug delivery device and aligned with at least one visual indicator of the one or more of visual indicators.